Chapter 06
Medicine
Stanford's medicine chapter shows AI moving on two fronts at once: molecular and virtual-cell models on the research side, and concrete workflow automation on the clinical side.
Why it matters
Medicine is one of the clearest examples of AI value meeting regulation, evidence burden and workflow reality all at once.
How to apply it
Read it as a split between discovery and delivery: powerful models are emerging, but clinical adoption depends on trust, workflow fit and evidence quality.
Core signals
Core signals
Domain-specific models routinely outperform much larger general ones in biology, and clinical workflow automation is already delivering measurable time and cost reductions.
Smaller specialized models are highly competitive
Stanford highlights several biology systems where smaller models outperform much larger ones, suggesting that data curation and domain design can beat brute-force scale.
Clinical workflow automation is already tangible
The chapter points to broad adoption of note-generation tools and large diagnostic performance gaps between strong multi-agent systems and unaided physicians on difficult published cases.
Selected data points
Selected data points
Condensed numbers and comparisons pulled from the official Stanford chapter materials.
| Signal | Value | Context |
|---|---|---|
| Protein / genomics size comparison | 111M / 200M vs 40B | Stanford cites 111M- and 200M-parameter biology models outperforming much larger baselines, including a 40B-parameter model. |
| Clinical note time reduction | Up to 83% | Physicians reported spending up to 83% less time writing notes after adoption of AI note tools. |
| Reported ROI | 112% | One hospital system reported a 112% return on investment from AI note-generation tools. |
| FDA AI medical devices in 2025 | 258 | The FDA authorized 258 AI medical devices in 2025. |
| Diagnostic orchestrator vs unaided physicians | 85.5% vs 20% | Microsoft's AI Diagnostic Orchestrator with OpenAI o3 scored 85.5% on difficult case studies versus 20% for unaided physicians. |
Implications
- Medical AI is becoming simultaneously more useful and more regulatorily complicated.
- Workflow automation may scale faster than fully autonomous clinical decision-making.
- Evidence quality remains the hard constraint when deployment stakes are high.